Friday, 9 November 2018

Mylan and Theravance Biopharma's COPD treatment gets FDA approval

Theravance Biopharma Inc and partner Mylan NV on Friday won U.S. regulatory approval for their treatment for a chronic lung condition that causes breathing-related problems.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)